What was Danaher's financial performance in the first quarter of 2007?

Danaher reported a strong first quarter in 2007. Net earnings were $254.8 million ($0.78 per diluted share), up from $215.7 million ($0.67 per diluted share) in the same period of 2006. Consolidated sales increased by 19% to $2.56 billion. Operating profit margins also improved to 14.7% from 13.9%.

How did acquisitions impact Danaher's results in Q1 2007?

Acquisitions were a significant driver of growth. They contributed approximately 12.5% to the 19% consolidated sales increase. Notably, the Medical Technologies segment experienced a 75% growth, largely due to acquisitions like Sybron Dental and Vision Systems Limited. However, these acquisitions also represented a major use of cash, with $297 million spent in the quarter.

What is the company's cash position and debt situation?

Cash and cash equivalents decreased to $197.6 million from $317.8 million at the end of 2006, primarily due to acquisition spending. Total debt stood at $2.325 billion, an increase driven by borrowings to finance these acquisitions. Despite the increased debt, Danaher reported compliance with all debt covenants.

Are there any significant accounting changes reported?

Yes, Danaher adopted FASB Interpretation No. 48 (FIN 48), 'Accounting for Uncertainty in Income Taxes,' on January 1, 2007. This adoption resulted in a $63.3 million decrease in the liability for unrecognized tax benefits, which was recorded as an increase to retained earnings.

DHR 10-Q Quarterly Report Q1 FY2007 — Revenue, Net Income, EPS

Summary

Danaher Corporation (DHR) reported a strong first quarter for 2007, with net earnings of $254.8 million, or $0.78 per diluted share, a significant increase from the prior year's $215.7 million, or $0.67 per diluted share. This growth was driven by a 19% increase in consolidated sales, which reached $2.56 billion. Acquisitions played a substantial role, contributing approximately 12.5% to sales growth, notably in the Medical Technologies segment. The company also saw a healthy improvement in operating profit margins, rising to 14.7% from 13.9% in the prior year, reflecting successful integration of acquisitions and ongoing efficiency improvements from the Danaher Business System (DBS). The company's balance sheet remains robust, although cash and equivalents decreased to $197.6 million from $317.8 million at year-end 2006, largely due to significant acquisition spending, including the acquisition of Vision Systems Limited and five other businesses. Despite increased debt levels to finance these acquisitions, particularly in the commercial paper market, Danaher maintained compliance with its debt covenants. The company also adopted new accounting standards for income taxes (FIN 48), which resulted in a favorable adjustment to retained earnings. Overall, Danaher demonstrated solid operational performance and strategic execution through acquisitions in the quarter.

Key Highlights

1Net earnings increased by approximately 18% year-over-year to $254.8 million, with diluted EPS rising to $0.78 from $0.67.
2Consolidated sales grew by 19% to $2.56 billion, with acquisitions contributing significantly (12.5%) to this growth.
3Operating profit margin improved to 14.7% from 13.9% in the prior year's comparable quarter.
4The Medical Technologies segment showed substantial growth (75%), driven by acquisitions including Sybron Dental and Vision Systems Limited.
5Cash paid for acquisitions was substantial at $297 million in the quarter, leading to a decrease in cash and equivalents.
6The company adopted FASB Interpretation No. 48 (FIN 48) for accounting for uncertainty in income taxes, resulting in a $63.3 million decrease in the liability for unrecognized tax benefits.
7Total debt increased, primarily due to borrowings to finance recent acquisitions, but the company remained in compliance with all debt covenants.

DANAHER CORP /DE/ Quarterly Report for Q1 Ended Mar 30, 2007

Summary

Key Highlights

Frequently Asked Questions